{"id":"NCT03102606","sponsor":"BeyondSpring Pharmaceuticals Inc.","briefTitle":"Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3","officialTitle":"A Phase 3, Multicenter, Randomized, Double Blind, Study to Evaluate Duration of Severe Neutropenia With Plinabulin Versus Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy (Protective 1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-05-29","primaryCompletion":"2018-12-12","completion":"2021-02-08","firstPosted":"2017-04-06","resultsPosted":"2024-08-29","lastUpdate":"2024-08-29"},"enrollment":105,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chemotherapy-induced Neutropenia"],"interventions":[{"type":"DRUG","name":"Plinabulin","otherNames":["BPI-2358","NPI-2358"]},{"type":"DRUG","name":"Pegfilgrastim","otherNames":["Neulasta","G-CSF"]},{"type":"OTHER","name":"Saline Placebo","otherNames":[]},{"type":"OTHER","name":"D5W Placebo","otherNames":[]}],"arms":[{"label":"Docetaxel (75 mg/m2) + pegfilgrastim (6 mg) + placebo matching plinabulin","type":"ACTIVE_COMPARATOR"},{"label":"Docetaxel (75 mg/m2) + plinabulin (40 mg) + placebo matching pegfilgrastim","type":"EXPERIMENTAL"}],"summary":"To assess Duration of Severe Neutropenia (DSN) in treatment Cycle 1 in patients with advanced or metastatic breast cancer, who have failed \\>/= 1 but \\< 5 prior lines of chemotherapy; locally advanced or metastatic non small cell lung cancer (NSCLC) after platinum therapy failure; or hormone refractory (androgen independent) metastatic prostate cancer treated with docetaxel (75 mg/m2) + plinabulin (40 mg) versus docetaxel (75 mg/m2) + pegfilgrastim (6 mg). Neutrophils count will be assessed at baseline; Pre dose during Cycle 1, Day 1, 2, 6, 7, 8, 9, 10, 15.\n\n\\*Study is officially closed on 08 Feb 2021\\*","primaryOutcome":{"measure":"Duration of Severe Neutropenia (DSN)","timeFrame":"21 Days","effectByArm":[{"arm":"Docetaxel (75 mg/m2) + Pegfilgrastim (6 mg) + Placebo Matching Plinabulin","deltaMin":0.246,"sd":null},{"arm":"Docetaxel (75 mg/m2) + Plinabulin (40 mg) + Placebo Matching Pegfilgrastim","deltaMin":0.77,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":18,"countries":["United States","China","Russia","Ukraine"]},"refs":{"pmids":["35084480","32970104"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":53},"commonTop":["Alopecia","Neutrophil count decreased","Bone pain","White blood cell count decreased","Anemia"]}}